Tinea capitis | | | | | | | | |
| | | Microsize (Grifulvin V suspension): 20 to 25 mg per kg per day; single daily dose or two divided doses (maximum: 1 g per day) Ultramicrosize (Gris-Peg tablets): 10 to 15 mg per kg per day; single daily dose or two divided doses (maximum: 750 mg per day)
| | | No baseline testing in absence of liver disease If required for longer than eight weeks, ALT, AST, bilirubin, and creatinine measurements and CBC every eight weeks2,17
| | |
| | | < 25 kg (55 lb): 125 mg once daily 25 to 35 kg (55 lb to 78 lb): 187.5 mg once daily > 35 kg (78 lb): 250 mg once daily
| | | | | |
| | Tablets: 50 mg, 100 mg, 150 mg, 200 mg Suspension: 10 mg per mL, 40 mg per mL
| | Tablets: $100 for 30 150-mg tablets ($1,185 for 90 50-mg tablets) Suspension: $33 ($290) for 35 mL of 40-mg-per-mL suspension
| | | | |
| | Solution: 10 mg per mL Capsules: 100 mg
| Capsules: 5 mg per kg daily for four to six weeks or Solution: 3 mg per kg daily for four to six weeks or Pulse therapy with capsules: 5 mg per kg daily for one week each month for two to three months or Pulse therapy with oral solution: 3 mg per kg daily for one week each month for two to three months Maximum: 500 mg per day
| | | | | |
Tinea unguium (onychomycosis) | | | | | | |
| | | | | | | | |
| | | 10 to 20 kg (22 to 44 lb): 62.5 mg daily 20 to 40 kg (44 to 89 lb): 125 mg daily 40 kg (89 lb) or more and adults: 250 mg daily
| | | Baseline ALT and AST measurement, CBC ALT and AST measurement, CBC at six weeks
| | |
| | Tablets: 50 mg, 100 mg, 150 mg, 200 mg Suspension: 10 mg per mL, 40 mg per mL
| | Tablets: $100 for 30 150-mg tablets ($1,185 for 90 50-mg tablets) Suspension: $33 ($290) for 35 mL of 40-mg-per-mL suspension
| | Baseline ALT, AST, alkaline phosphatase, and creatinine measurements, CBC No repeat needed for once weekly therapy
| | |